A Randomized Trial of Ketorolac vs. Sumatripan vs. Placebo Nasal Spray (KSPN) for Acute Migraine

about

A Randomized Trial of Ketorolac vs. Sumatripan vs. Placebo Nasal Spray (KSPN) for Acute Migraine

Item

http://www.wikidata.org/entity/Q36771091

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

A Randomized Trial of Ketorola ...... pray (KSPN) for Acute Migraine

@ast

A Randomized Trial of Ketorola ...... pray (KSPN) for Acute Migraine

@en

type

Item

label

A Randomized Trial of Ketorola ...... pray (KSPN) for Acute Migraine

@ast

A Randomized Trial of Ketorola ...... pray (KSPN) for Acute Migraine

@en

prefLabel

A Randomized Trial of Ketorola ...... pray (KSPN) for Acute Migraine

@ast

A Randomized Trial of Ketorola ...... pray (KSPN) for Acute Migraine

@en

P1476

A Randomized Trial of Ketorola ...... pray (KSPN) for Acute Migraine

@en

P2093

Aruna S Rao

http://www.w3.org/2001/XMLSchema#string

B Lee Peterlin

http://www.w3.org/2001/XMLSchema#string

Haley Nitchie

http://www.w3.org/2001/XMLSchema#string

Paul D Dash

http://www.w3.org/2001/XMLSchema#string

P2860

The International Classification of Headache Disorders: 2nd edition

Defeating migraine pain with triptans: a race against the development of cutaneous allodynia.

A review of intranasal ketorolac tromethamine for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level.

Intranasal ketorolac tromethamine (SPRIX(R)) containing 6% of lidocaine (ROX-828) for acute treatment of migraine: safety and efficacy data from a phase II clinical trial.

Ketorolac in the treatment of acute migraine: a systematic review.

The global burden of headache: a documentation of headache prevalence and disability worldwide.

Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine

Improved identification of allodynic migraine patients using a questionnaire.

Intranasal zolmitriptan for the treatment of acute migraine.

The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies.

P304

331-340

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HEAD.12767

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tobias Kurth

Bizu Gelaye

P577

2016-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

292978218

http://www.w3.org/2001/XMLSchema#string

P698

26840902

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder

placebo

P932

4822712

http://www.w3.org/2001/XMLSchema#string